MedPath

Daily Vitamin D Supplementation Compared to a Loading Dose and Monthly Supplementation in Elderly Nursing Home Residents

Phase 3
Completed
Conditions
Vitamin D Deficiency in Older Persons
Registration Number
NCT01168544
Lead Sponsor
Rijnstate Hospital
Brief Summary

Vitamin D deficiency is common in older persons, in particular in residents of nursing homes. This is mainly explained by the fact that older persons do not often go outside in the sunshine. On top of that the capacity of the skin to synthesize provitamin D is decreased and dietary vitamin D intake is low. Vitamin D deficiency leads to osteoporosis, falls and fractures. To prevent morbidity and mortality due to falls and fractures it seems logical to supplement vit D in order to correct the deficiency. The advised daily dose of vit D supplementation is 800 IU. Several studies showed that with this dose the required serum 25(OH)D levels will not be reached.

primary objective of this study is:

* to investigate whether with a loading dose based on body weight and baseline serum 25(OH)D level more patients reach adequate serum 25(OH)D levels compared to 800 IU a day.

* to determine the best consolidation treatment.

Secondary objective

* is a loading dose based on body weight and baseline serum 25(OH)D level safe to use in residents of nursing homes.

* is there a relation between the increase in serum 25(OH)D level and muscle strength (handgrip strength).

* is there a relation between the increase in serum 25(OH)D level and mobility (2 minute walk test).

Study design:

Randomised trial with 3 study groups:

* Group 1a. loading dose based on body weight and baseline serum 25(OH)D level + 50.000 IU vit D3/month consolidation therapy.

* Group 1b. loading dose based on body weight and baseline serum 25(OH)D level + 25.000 IU vit D3/month consolidation therapy.

* Group 2. 800 IU vit D3/ dag.

Study population:

Vitamine D deficient residents of nursing homes, 65 years or older.

Detailed Description

Not available

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
160
Inclusion Criteria
  • Long term indication for living in a residential home for the elderly
  • Age > 65 years
  • Vitamin D deficiency (serum 25- hydroxycholecholecalciferol (25(OH)D3 < 50 nmol/l)
  • Informed Consent
Exclusion Criteria
  • Hypercalcemia (serum CA > 2.60 mmol/l)
  • Life expectancy < 1/2 year
  • Multivitamin use including > 400 IE vit D
  • Non-functional dominant arm

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Primary Outcome Measures
NameTimeMethod
Proportion of patients reaching an adequate serum 25(OH)D level (75-150 nmol/l)
Secondary Outcome Measures
NameTimeMethod
Proportion of patients reaching a serum 25(OH)D level > 220 nmol/l
Handgrip strength
Distance achieved in a 2 minute walk test

Trial Locations

Locations (1)

Alysis Zorggroep, verpleeghuis zevenaar

🇳🇱

Zevenaar, Gelderland, Netherlands

Alysis Zorggroep, verpleeghuis zevenaar
🇳🇱Zevenaar, Gelderland, Netherlands

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.